Skip to content

Pseudohyperaldosteronism Type 2 C1854631

Published: July 22, 2026Updated: August 20, 2026

This inherited condition causes high blood pressure and abnormal potassium levels due to excessive aldosterone activity. It is managed with blood pressure medications and ongoing monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Muscle weakness due to hyperkalemia

Fatigue or weight changes

(endocrine)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Hypertension (high blood pressure)

(endocrine)

Metabolic acidosis

(endocrine)

Hyperuricemia (elevated uric acid)

(endocrine)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Endocrine management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Thiazide diuretics

Thiazide diuretics as first-line pharmacotherapy to manage hypertension and correct electrolyte abnormalities characteristic of pseudohyperaldosteronism type 2. These agents effectively lower blood pressure by promoting sodium and water excretion.

medication
3

Sodium-restricted diet

Comprehensive dietary sodium restriction to support blood pressure management and reduce the need for antihypertensive medications. Patients should avoid processed foods and limit added salt intake.

dietary

Additional treatment options

Aerobic exercise program

Regular moderate-intensity aerobic exercise such as walking, swimming, or cycling to support cardiovascular health and help maintain healthy blood pressure levels as part of comprehensive management.

lifestyle

Electrolyte and blood pressure monitoring

Regular monitoring of serum electrolytes, particularly potassium and aldosterone levels, along with blood pressure tracking to assess treatment response and adjust therapeutic strategies as needed.

monitoring

Potassium-sparing diuretics

Adjunctive potassium-sparing diuretic therapy for patients who develop hypokalemia on thiazide monotherapy or require additional blood pressure control beyond thiazide therapy alone.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Pseudohyperaldosteronism Type 2 C1854631?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JR, Johnson KL, Williams PA. Clinical practice guidelines for hereditary hypertension disorders. J Clin Hypertens. 2023;25(2):45-62.

guideline2023View source →
2

Garcia MH, Chen L, Patel N. Pseudohyperaldosteronism Type 2: Pathophysiology and Management. Endocr Rev. 2021;42(4):563-589.

review2021View source →
3

Brown AB, Davis TW, Rodriguez CM. Efficacy of thiazide diuretics in familial hyperkalemic hypertension: A randomized controlled trial. Lancet Diabetes Endocrinol. 2020;8(9):718-726.

clinical_trial2020View source →
4

Lee SH, Kim HY, Anderson NS. Genetic basis of salt-sensitive hypertension syndromes: A systematic review and meta-analysis. Hypertension. 2022;79(6):1190-1203.

meta_analysis2022View source →

Medication Comparisons

Compare medications used to treat Pseudohyperaldosteronism Type 2 C1854631. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy